AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations
AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, has agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced today. AstraZeneca markets and sells pharmaceutical products in the United States, including a drug sold under the trade name Nexium.
- Date:February 11, 2015
- Agency:U.S. Department of Justice
- Criminal and Civil Actions